A double-blind, placebo-controlled, proof-of-concept clinical study assessing the effect of ACP-103 on deep, or slow wave, sleep in healthy older volunteers.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 May 2016
At a glance
- Drugs Pimavanserin (Primary)
- Indications Insomnia
- Focus Proof of concept; Therapeutic Use
- 06 May 2016 New trial record.